Corvus Pharmaceuticals
Dan Li is currently working at Corvus Pharmaceuticals as a Senior Scientist and Manager, focusing on designing, developing, and executing the mechanism of action with ITK inhibition in various medical conditions. Dan Li was previously an Instructor at UT Health San Antonio and a Postdoctoral Fellow at Stanford University School of Medicine. Dan Li holds a Bachelor of Science in Pharmaceutical Sciences from China Pharmaceutical University and a Doctor of Philosophy in Physiology from Peking University Health Science Center. Dan Li was also a coauthor in a poster presented at the AACR annual meeting in 2023.
This person is not in any offices
Corvus Pharmaceuticals
2 followers
Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development of novel, first-in-class agents that target the immune system to treat patients with cancer.